CIK 0001469443
- Non-accelerated filer
- Smaller reporting company
Arcadia Biosciences, Inc.
Sign in to watch- Ticker
- RKDA
- Exchange
- Nasdaq
- Industry
- Beverages
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810571538
- Phone
- +1 214-974-8921
- Business address
- 5956 SHERRY LANE, SUITE 2000, DALLAS, TX
- 4 Exercise or conversion VP Finance and Administration acquired 10,000 shares (option exercise)
- 4 Open-market sale President and CEO sold 21,636 shares at an average $3.07 ($66,417)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Open-market sale President and CEO sold 15,900 shares at an average $3.46 ($54,951)
- 4 Open-market sale President and CEO sold 21,089 shares at an average $4.27 ($90,131)
- 4 Open-market sale VP Regulatory and Compliance sold 3,521 shares at an average $4.95 ($17,433)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 17,500 shares (option exercise)
- 4 Open-market sale VP Business Development sold 1,648 shares at $4.92 ($8,105)
- 4 Open-market sale VP Product Development sold 1,068 shares at $4.92 ($5,253)
- 4 Open-market sale VP Business Development sold 7,840 shares at an average $5.47 ($42,917)
- 4 Open-market sale VP Product Development sold 6,672 shares at an average $5.48 ($36,533)
- 4 Open-market sale Chief Scientific Officer sold 6,840 shares at an average $5.50 ($37,646)
- 4/A Open-market buy Director bought 375,000 shares at $8.00 ($3,000,000)
- 4/A Open-market buy 10% owner bought 375,000 shares at $8.00 ($3,000,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 375,000 shares at $8.00 ($3,000,000)
- 4 Open-market buy Director bought 375,000 shares at $8.00 ($3,000,000)
- 4 Open-market buy Director bought 1,000,000 shares at $8.00 ($8,000,000)
- 4 Derivatives Options or other derivatives
Page 9 of 11 · 203 filings